12:01 IST
NSE
Board Meeting Date
Beta Drugs Board Meeting Date
Beta Drugs Limited has scheduled a board meeting for September 3, 2026. The agenda includes fixing the 21st AGM details and approving the Director’s Report.
Beta Drugs Ltd
- Share price
- ₹1,991.40
- Market cap
- ₹2,208 Cr
- Revenue (annual)
- ₹384.8 Cr
- Net profit (annual)
- ₹41.48 Cr
- P/E (TTM)
- 48.4×Sector 47.3×
- Promoter holding
- 59.10%-5.53% QoQ
- FII holding
- 1.02%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Fund Raise 4Earnings Call 3Board Meeting Date 3Financial Results 2Board Meeting Outcome 2Results Correction 1Regulatory Approval 1Price Movement Clarification 1Other Announcement 1Management Change 1Capital Structure Change 1Business Update 1Annual General Meeting 1Acquisition 1
Time
3 announcements with these filters
20:46 IST
NSE
Board Meeting Date
Beta Drugs Board Meeting Date
Beta Drugs scheduled a board meeting for July 20, 2026. The board will review unaudited quarterly financial results for the period ended June 2026.
16:54 IST
NSE
Board Meeting Date
Beta Drugs Board Meeting Date
Beta Drugs scheduled a board meeting for May 14, 2026, to review audited annual financial results. The trading window remains closed until May 16.